26 August 2012

EU releases updated Pharmacovigilance Monitoring Plan

The European Medicines Agency (EMA) has released an updated pharmacovigilance management plan to deal with the introduction and proliferation of unsafe medicines into the EU's pharmaceutical supply chain.
In its 13 August 2012 posting, EMA explained its plan, has been in operation for nearly three years and applies to all medicines approved within the EU, including those approved by the decentralized and mutual recognition procedures. The plan had recently been updated to reflect the EU's new pharmacovigilance legislation, which should allow regulators to responds to serious and potential threats even faster, EMA said.
"Although the management of the large majority of emerging public health concerns related to the use of medicines has been possible by applying so-called routine measures, in a limited number of cases, commonly described as 'crisis' situations, specific measures had to be taken to allow for an efficient management," EMA explained. "This has been possible through the availability of dedicated 'crisis' management plans at national level."

The Regulatory Network Incident Management Plan (RNIMP) in Theory

As part of the plan, EMA said it conducts continuous monitoring of serious adverse events to understand their effects on the broader healthcare system—a process it refers to as proactive incident management. By actively monitoring events, it said it hopes to prevent crises from occurring in the first place with the help of a flexible framework that allows for a coordinated and expeditious response.
The agency said signed Memoranda of Understanding between EMA and National Competent Authorities (NCAs) to share EudraVigilance data and other safety data are a strong component of the coordinated response portion of the plan.  "This should allow for a more global approach at EU level in relation to the management of 'crisis' situations," noted EMA.
While the plan is intended to cover a range of issues—quality, efficacy and safety concerns among them—EMA said the majority of cases, in its experience, concern pharmacovigilance issues. Many of these problems require an EU-wide response immediately to take a product off the market or conduct more targeted vigilance measures. EMA also noted that emerging issues may be elevated to an EU-wide response if they are deemed to be a serious potential threat.

The RNIMP in Practice

EMA describes the plan as consisting of two pillars of support: a dedicated management structure contained at the EU-wide level and a procedure administered by the former.
The management structure takes a bifurcated approach toward the exchange of information. A Rapid Alert system communicates urgent safety risks to regulators, while a Non-Urgent Information system funnels potentially serious incidences to the same. Both sets are reviewed by the Incident Review Network—a digital network of EU regulators from EMA, NCAs and the European Commission—which then recommends action to the EU crisis management team.
This crisis management team is composed of an EU Executive Task Force charged with confirming a crisis and initiating a response and an EU Operational Task Force charged with responding to the crisis and recommending changes to avoid the crisis in the future.
The entire RINMP involves a seven step process in which it monitors a threat, evaluates it, confirms the threat is a crisis, initiates and monitors a response, confirms the crisis has been abated and takes steps to determine how it could be prevented from happening again.
Pharmacovigilance Monitoring Plan

9 comments:

  1. Excellent post. I really enjoy reading and also appreciate your work. This concept is a good way to enhance knowledge. Keep sharing this kind of articles, Thank you. order injectable steroids online usa

    ReplyDelete
  2. It’s actually a great and helpful piece of info. I’m happy that you just shared this helpful info with us. Please keep us informed like this. Thanks for sharing! Best ethics compliance training service provider.

    ReplyDelete
  3. It is what I was searching for is really informative. It is a significant and useful article for us. Thankful to you for sharing an article like this. Pharmacovigilance Companies

    ReplyDelete
  4. Remarkable post, The information you have mentioned is really knowledgeable and engaging for us, I really enjoyed reading it. Thank you for sharing this. Hire Remote Pharmacist

    ReplyDelete
  5. I found decent information in your article. I am impressed with how nicely you described this subject, It is a gainful article for us. Thanks for share it. teen mental health service simi valley ca

    ReplyDelete
  6. Excellent job, this is great information which is shared by you. This info is meaningful and factual for us to increase our knowledge about it. about Best Cardiology Hospital in Pune So please always keep sharing this type of information.

    ReplyDelete
  7. Excellent job, this is great information which is shared by you. This info is meaningful and factual for us to increase our knowledge about it. about Wellness Clinic Wakad So please always keep sharing this type of information.

    ReplyDelete
  8. Excellent job, this is great information which is shared by you. This info is meaningful and factual for us to increase our knowledge about it. about Gynaecologist North Sydney So please always keep sharing this type of information.

    ReplyDelete
  9. Present a viewpoint that neither you nor your spouse would have considered. Assist you in foreseeing and resolving potential future problems before they arise (such preventative help is often a goal of pre-marital counseling) Therapist Cincinnati

    ReplyDelete